In this article, Professor David Orentlicher argues that when a patient could be offered one of multiple established treatments, doctors should be able to offer treatment only if the patient agrees to participate in research aimed at determining which of the treatments is most effective. Making treatment conditional on research participation will help researchers complete badly needed studies
Today, the world is facing pandemic outburst of diseases. Many Physicians-Scientist are working real...
Background: The Institute of Medicine estimates that only a maximum of 25% of clinical research find...
BACKGROUND: Institutional Review Boards vary in regard to the conditions imposed on investigators co...
In this article, Professor David Orentlicher argues that when a patient could be offered one of mult...
oai:ojs2.jmrionline.com:article/2Healthcare decision-making is mostly reliant on evidence–based medi...
We argue that charging people to participate in research is likely to undermine the fundamental ethi...
The development of life-saving drugs and cutting-edge treatments depends on people participating in ...
This article will explore the realm of clinical research and the question of who should finance such...
The Author(s) 2014. This article is published with open access at Springerlink.com Medical researche...
Patients participating in the shared benefits of publicly funded health care enjoy the benefits of t...
New National Institutes of Health policies call for expansion of practice-based research to improve ...
This article addresses two areas of continuing controversy about consent in clinical research: the q...
This Article seeks to bring greater discipline to the analysis of conflicts of interest in biomedica...
Health insurance coverage for experimental treatments has generated significant debate and frequent ...
Chapter 11 of: Kushner, Thomasine Kimbrough, editor. 2010. Surviving health care: a manual for patie...
Today, the world is facing pandemic outburst of diseases. Many Physicians-Scientist are working real...
Background: The Institute of Medicine estimates that only a maximum of 25% of clinical research find...
BACKGROUND: Institutional Review Boards vary in regard to the conditions imposed on investigators co...
In this article, Professor David Orentlicher argues that when a patient could be offered one of mult...
oai:ojs2.jmrionline.com:article/2Healthcare decision-making is mostly reliant on evidence–based medi...
We argue that charging people to participate in research is likely to undermine the fundamental ethi...
The development of life-saving drugs and cutting-edge treatments depends on people participating in ...
This article will explore the realm of clinical research and the question of who should finance such...
The Author(s) 2014. This article is published with open access at Springerlink.com Medical researche...
Patients participating in the shared benefits of publicly funded health care enjoy the benefits of t...
New National Institutes of Health policies call for expansion of practice-based research to improve ...
This article addresses two areas of continuing controversy about consent in clinical research: the q...
This Article seeks to bring greater discipline to the analysis of conflicts of interest in biomedica...
Health insurance coverage for experimental treatments has generated significant debate and frequent ...
Chapter 11 of: Kushner, Thomasine Kimbrough, editor. 2010. Surviving health care: a manual for patie...
Today, the world is facing pandemic outburst of diseases. Many Physicians-Scientist are working real...
Background: The Institute of Medicine estimates that only a maximum of 25% of clinical research find...
BACKGROUND: Institutional Review Boards vary in regard to the conditions imposed on investigators co...